The Rise of Artron Laboratories
A Story of Innovation and Dedication
Providing High-Quality IVD Products Since 2002
Artron Laboratories was founded in 2002 with a mission to provide the highest quality in-vitro diagnostic (IVD) products to its clients. From the very beginning, the company's focus was on innovation and dedication to delivering reliable and accurate testing solutions.
Artron Receives Funding from NRC IRAP to Advance R&D Efforts
In 2003, Artron received funding from The National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), which allowed the company to further its research and development efforts. This support allowed Artron to establish itself as a leading provider of IVD products in the industry.
Artron Expands Globally with New Base in China
Four years later, in 2007, Artron established an overseas base in Shandong, China, which allowed the company to expand its reach and serve clients on a global scale. This was a key turning point for Artron as it marked the beginning of the company's international presence.
Artron expands mission to share expertise through global sales and technology transfer services
In 2012, Artron started global sales of biomaterials and began offering technology transfer services to companies in the industry. This marked the start of Artron's mission to not only provide quality products, but also to share its expertise and knowledge with others in the field.
Artron receives CE approval for HIV/HCV/HBsAg Combo Test
Two years later, in 2014, Artron received CE approval for its HIV/HCV/HBsAg Combo Test, which was a major milestone for the company. This product demonstrated Artron's commitment to delivering the latest and most advanced testing solutions to its clients
Artron Expands Product Offerings with GMO and Food Safety Tests
In 2015, Artron released its GMO and Food Safety Test product lines, further expanding the company's product offerings and solidifying its position as a leading provider of IVD products.
Artron Laboratories establishes Chemiluminescence Division in 2017
In 2017, Artron established its Chemiluminescence Division, which was a testament to the company's continued dedication to innovation and growth. This division allowed Artron to provide even more advanced testing solutions to its clients.
Artron Laboratories Inc. forms joint venture for R&D and product expansion
In 2019, Artron founded a joint venture, "BioArtron Diagnostics Inc." This joint venture was formed with the goal of furthering the company's research and development efforts, as well as expanding its product offerings.
Artron Laboratories wins major international procurement tender in 2020
In 2020, Artron won a major procurement tender from the Egyptian government, further solidifying the company's presence in the international market. This was a major achievement for the company, and a testament to the quality of its products and services.
Artron's Covid-19 Antigen Test: A Success Story of Innovation and Dedication
In 2021 and 2022, Artron's commitment to innovation and dedication to providing reliable testing solutions was on full display as the company obtained Health Canada/CE/WHO approval for its Covid-19 Antigen Test. The company also won a tender from the Canadian government for its Covid-19 Antigen Test, which was a major accomplishment and demonstrated Artron's ability to quickly and effectively respond to the needs of its clients during a global pandemic.
Artron Laboratories: Leading the Way in IVD Testing Solutions
Today, Artron Laboratories continues to be a leader in the IVD industry, providing high-quality and reliable products to its clients. With its commitment to innovation, dedication to customer service, and a focus on affordability and convenience, Artron is the ideal choice for all your diagnostic testing needs.